r. Frank Scholz is executive vice president of global operations and president, Specialty Generics at Mallinckrodt Pharmaceuticals. His responsibilities include all aspects of the Specialty Generics business, as well as the broader global branded manufacturing operations, quality and supply chain functions for the company. Dr. Scholz is a member of Mallinckrodt’s executive committee. Dr. Scholz has more than 15 years of experience in the pharmaceutical and medical devices industries. Prior to joining Mallinckrodt, Dr. Scholz was a partner with McKinsey & Company, a global management consulting firm. Dr. Scholz was a leader in McKinsey’s global pharmaceutical and operations practices. Prior to joining McKinsey, Dr. Scholz was a research assistant at the Institute for Management and Accounting at the University of Hannover in Germany. Dr. Scholz holds a master’s degree in economics from the University of Hannover, Germany; an MBA from Georgetown University; and a doctorate in economics and business management from Bielefeld University in Germany.